Skip to main content

Fiscal Wizard · Single-issue tearsheet

AGMB / Jun 21, 2026 Run #7367

AGMB

AgomAb Therapeutics NV

AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases in the United States. The company's product pipeline includes Ontunisertib (AGMB-129), an oral gastrointestinal-restricted small molecule inhibitor of ALK5 or TGFßR1 for the treatment of Fibrostenosing Crohn's disease, which is in Phase 2a clinical trials; and AGMB-447, an inhaled small molecule inhibitor of ALK5 or TGFßR1 for the treatment of idiopathic pulmonary fibrosis that is in Phase 1 clinical trials. It also develops AGMB-101, a HGF-mimetic monoclonal antibody that acts through agonism or stimulation of the MET receptor and has demonstrated antifibrotic and regenerative activity in preclinical models. The company was incorporated in 2017 and is headquartered in Antwerp, Belgium.

Composite verdict

F 27.6 / 100
Bearish setup · Trend Following 14 drivers · 1 gate blocking
  • Accumulation/Distribution Line
  • Chaikin Money Flow
  • Bollinger Reentry
  • Rate of Change
  • MA Rejection
  • Sushi Roll
Consider long put target Δ ~0.60 · ~35 DTE Bearish setup, Grade B → ITM put target

Industry rank 189th of 598 in Biotechnology

rescore-sweep
Technical synthesis
Bull 10%Evidence: Medium · 30 signals90% Bear
Momentum Bearish 7Mean-reversion Neutral 54

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

25.0 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Free Cash Flow Yield 0
Return on Equity 25
Asset Turnover 25

Technicals Bearish

30.1 / 100

Bearish setup leads (Rate of Change, MA Rejection, Sushi Roll). · 43 signals shown.

Strongest
Weakest
Accumulation/Distribution Line 98
Rate of Change 8
Chaikin Money Flow 88
Vortex Signal 12
Bollinger Reentry 76
Sushi Roll 15

Risk Gates

1 blocking 3 caution

1 guard active, 2 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Sloan Ratio Caution

Visual accruals-quality flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for AGMB.